Krystal Biotech, Inc. KRYS Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $225.03M+9.9% | $204.83M+3.0% | $198.91M+35.6% | $146.73M+18.4% | $123.96M+39.0% | ||
| $5.78M+2.0% | $5.67M+3.6% | $5.47M+1.9% | $5.37M-8.5% | $5.87M-0.3% | ||
| $54.65M+0.2% | $54.51M+0.8% | $54.11M-0.3% | $54.27M+1.8% | $53.31M+8.5% | ||
| $250.28M+24.6% | $200.87M+14.0% | $176.2M-9.8% | $195.4M+37.0% | $142.67M+11.8% | ||
| $12.9M+7.9% | $11.95M+12.6% | $10.61M+6.6% | $9.96M+8.4% | $9.18M+117% | ||
| —— | —— | -$153.36M+16.4% | -$183.4M+4.6% | -$192.23M-17.6% | ||
| —— | —— | —— | —— | $3.97M-85.3% | ||
| $192.54M+27.1% | $151.44M+713% | $18.64M+132% | $8.04M+116% | -$50.24M-273% | ||
| $237.38M+25.7% | $188.91M+14.1% | $165.59M-10.7% | $185.44M+37.8% | $134.62M+8.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Krystal Biotech, Inc. generate?
- Krystal Biotech, Inc. (KRYS) generated $250.3M in operating cash flow over the trailing twelve months.
- What is Krystal Biotech, Inc.'s free cash flow?
- After $12.9M of capital expenditures, Krystal Biotech, Inc.'s free cash flow was $237.4M over the trailing twelve months, up 76.3% year over year.
- Where does Krystal Biotech, Inc.'s cash flow data come from?
- Every line is extracted from Krystal Biotech, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
